FUSED RING HETEROARYL COMPOUNDS AND THEIR USE AS TRK INHIBITORS

The disclosure provides novel chemical compounds represented by Formula (I) or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof. The compounds can be used as an inhibitor of Trk and are useful in the treatment of pain, cancer, inflammation, neurodegenerative...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Moonsoo KIM, Gilnam LEE, Jeongbeob SEO, Minwoo LEE, Cheolhwan YOON, Hankyul JEONG, Hyun, Jung KIM, Hyang CHOI, Ki, Nam LEE, Chaewoon LEE, Misoon KIM, Soongyu CHOI, Myung, Eun JUNG, Hye, Kyoung KIM, Jay, Hak KIM, Jae LEE II
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The disclosure provides novel chemical compounds represented by Formula (I) or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof. The compounds can be used as an inhibitor of Trk and are useful in the treatment of pain, cancer, inflammation, neurodegenerative disease and certain infectious diseases. In some compounds of Formula I, Q is -CH=CR3C(O)Nr4R5, -C=CC(O)NR4R5,-C≡ CC(0)NR4R5, or (II). La descripción proporciona compuestos químicos novedosos representados por la Fórmula I o una sal, solvato, polimorfo, éster, tautómero o profármaco farmacéuticamente aceptable de los mismos. Los compuestos pueden utilizarse como un inhibidor del Trk y son útiles en el tratamiento del dolor, cáncer, inflamación, enfermedad neurodegenerativa y ciertas enfermedades infecciosas. (ver Fórmula). En algunos compuestos de la Fórmula I, Q es -CH=CR3C (O) NR4R5, -C?CC (O) NR4R5, o (ver Fórmula).